US$ 27.13
when were glp 1 agonists approved GLP-1R for Weight Loss DID YOU KNOW? GLP-1 medications
Description
China is Next Big Market: Manufacturing Challenges, Supply Shortages
The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031

For external use only

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.
Bioavailable forms of Vitamin B12, L-Methylfolate, and CoQ10 are packed into each capsule to support energy production at the cellular level
